POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES
Domain expertise, global resource, long-term capital
PORTFOLIO NEWS
2019年10月31日PHILADELPHIA, October 31, 2019 -- Tmunity Therapeutics, Inc. in pursuit of its vision to save and...FOSTER CITY, Calif. & SHANGHAI--(BUSINESS WIRE)-- Terns Pharmaceuticals, Inc., a global...BEIJING and SHANGHAI , Oct. 25, 2019 /PRNewswire/ -- Recently, Fountain Medical Development...SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- dMed Biopharmaceutical Co., Ltd. recently announced...IONOVA LIFE SCIENCE CO., LTD., China -- October 15, 2019 – IONOVA, a biotechnology company...Ansun BioPharma, Inc., a leading biotechnology company focused on the development of novel broad...HONG KONG, Sept. 10, 2019 /PRNewswire/ -- Insilico Medicine, a pioneer in next-generation...- Proceeds to support continued development of robust portfolio of AAV-delivered therapeutics...More Posts
Company
Shanghai
Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Hong Kong
Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong
US
2730 Sand Hill Road, Suite 130, Menlo Park, CA
All Posts
×
LillyAsiaVentures
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
http://user-assets.sxlcdn.com/images/315509/FnksTvTDur7jpExbqYminmtjWgoM.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png